Clinical Trial Results

Showing: All studies [change]
Condition: Alzheimer's Location: Missouri 25 trials found
New Search
Filter
Trial Phase
Study Type
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
ACP-204 in Adults With Alzheimer's Disease Psychosis
PHASE2, PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
PHASE3INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
NAINTERVENTIONAL Houston, Texas
RECRUITING
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
N/AOBSERVATIONAL Atlantis, Florida +4 more
RECRUITING
NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
NAINTERVENTIONAL Houston, Texas
RECRUITING
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
PHASE3INTERVENTIONAL Anaheim, California +4 more
RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
PHASE3INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
N/AOBSERVATIONAL Houston, Texas
RECRUITING
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
PHASE1, PHASE2INTERVENTIONAL Houston, Texas
RECRUITING
Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease
EARLY_PHASE1INTERVENTIONAL Houston, Texas
RECRUITING
Stem Cell Therapy for Early Alzheimer's Disease
PHASE1, PHASE2INTERVENTIONAL Houston, Texas
RECRUITING
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
PHASE2INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease
NAINTERVENTIONAL Houston, Texas
RECRUITING
Open-label Extension Study in Participants With Early Alzheimer's Disease
PHASE2INTERVENTIONAL Maitland, Florida +4 more
RECRUITING
Epidemiology and Biomarker Study in Alzheimer's Disease
PHASE3INTERVENTIONAL Houston, Texas +3 more
RECRUITING
Phosphorylated Tau Levels in Donated Blood
N/AOBSERVATIONAL Houston, Texas
RECRUITING
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
PHASE2INTERVENTIONAL Anaheim, California +4 more
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type